INTEGRA increases global turnover by 46 %

INTEGRA Biosciences has reported considerable growth for over 10 years – averaging 18 percent per annum – and more than doubling in the previous two years. The company grew by 73 percent in 2020, and has followed this with a 46 percent increase in turnover in 2021, reaching 191 million Swiss Francs.

The life sciences industry is thriving, and there is currently unprecedented demand for liquid handling solutions. INTEGRA’s extensive portfolio of pipettes – including the recently launched MINI 96, a 96 channel portable electronic pipette – is trusted by laboratories worldwide, helping to drive the company’s continued expansion. The company attracted a further 1000 new customers in 2021, and hired an additional 100 employees to increase its global operating capacity. Similar results are expected in 2022, and the company is forecasting double-figure growth. This is likely to be driven by an increase in direct sales in multiple countries across Asia and Europe, as well as exciting new product launches. Construction of a new office and production building – the INTEGRA Campus – will continue at Zizers, and another 150 staff are planned to be employed across various sectors globally.  

Urs Hartmann, CEO at INTEGRA, commented: “Our innovative solutions make for a reliable partner in the lab, and 99 percent of our customers say that they would continue to use, and recommend, INTEGRA products. Creating a positive and safe working environment for our staff is crucial to the company’s success, together with ensuring that growth doesn’t compromise our long-term sustainability objectives.”

Visit the INTEGRA Biosciences website to learn more.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    INTEGRA Biosciences. (2022, February 08). INTEGRA increases global turnover by 46 %. News-Medical. Retrieved on December 11, 2023 from

  • MLA

    INTEGRA Biosciences. "INTEGRA increases global turnover by 46 %". News-Medical. 11 December 2023. <>.

  • Chicago

    INTEGRA Biosciences. "INTEGRA increases global turnover by 46 %". News-Medical. (accessed December 11, 2023).

  • Harvard

    INTEGRA Biosciences. 2022. INTEGRA increases global turnover by 46 %. News-Medical, viewed 11 December 2023,


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
You might also like...
INTEGRA Biosciences' vacuum aspiration systems help researchers solve the dog epigenome